Vermodje TESTOVER E 10ml 250mg/ml

Description

Manufacturer: Vermodje

Testosterone Enanthate, an injectable compound characterized by its delayed release rate, represents an esterified version of the hormone. The incorporation of the Enanthate ester into the Testosterone molecule facilitates this gradual release, ensuring sustained therapeutic effects.

Therapeutic Indication: Testosterone Enanthate finds application in males requiring replacement therapy due to insufficient or absent endogenous testosterone. Various conditions, including primary hypogonadism (resulting from testicular failure) and hypogonadotropic hypogonadism (stemming from gonadotropin or luteinizing hormone-releasing hormone deficiency), are effectively managed with this treatment.

Why Choose Testosterone Enanthate Over Conventional Medicine? With Testosterone Enanthate and other testosterone esters, blood testosterone levels experience a 400% surge within 24 hours post-treatment initiation, remaining elevated for 3 to 5 days after the initial injection. Continuous administration of Testosterone Enanthate results in notable reductions in serum dihydrotestosterone, prostate-specific antigen (PSA), high-density lipoprotein (HDL), follicle-stimulating hormone (FSH), and estradiol levels. Even after cessation of therapy, dihydrotestosterone and FSH levels may remain suppressed for up to 14 days. Importantly, the presence of Testosterone Enanthate does not adversely affect mood or sexual activity.

Pharmacological Actions: Testosterone exerts its effects through activation of the androgen receptor (directly or via conversion to dihydrotestosterone) and conversion to estradiol, subsequently activating specific estrogen receptors. Free testosterone interacts with the cytoplasm of target tissue cells, undergoing conversion to dihydrotestosterone by the cytoplasmic enzyme 5-reductase or binding to the androgen receptor. Dihydrotestosterone exhibits approximately 2.5 times greater androgenic potency than testosterone due to its enhanced binding affinity to the androgen receptor.

Usage Directions: For pellet administration, a subcutaneous dose of 150-450 mg every 3-6 months is recommended, with 150 mg of pellet approximately equivalent to 25 mg of testosterone propionate administered weekly.

Side Effects: Potential side effects of Testosterone Enanthate may include increased hemoglobin levels, elevated blood prolactin, upper respiratory tract infections, and increased hematocrit levels. Regular monitoring and medical supervision are advised to mitigate these effects and ensure optimal therapeutic outcomes.